journal article·2017-04-26

Near-Infrared Light Responsive Folate Targeted Gold Nanorods for Combined Photothermal-Chemotherapy of Osteosarcoma

Anna Li Volsi, Cinzia Scialabba, Valeria Vetri, Gennara Cavallaro, Mariano Licciardi, Gaetano Giammona

Publisher page

Abstract

Folate-targeted gold nanorods (GNRs) are proposed as selective theranostic agents for osteosarcoma treatment. An amphiphilic polysaccharide based graft-copolymer (INU-LA-PEG-FA) and an amino derivative of the α,β-poly(N-2-hydroxyethyl)-d,l-aspartamide functionalized with folic acid (PHEA-EDA-FA), have been synthesized to act as coating agents for GNRs. The obtained polymer-coated GNRs were characterized in terms of size, shape, zeta potential, chemical composition, and aqueous stability. They protected the anticancer drug nutlin-3 and were able to deliver it efficiently in different physiological media. The ability of the proposed systems to selectively kill tumor cells was tested on U2OS cancer cells expressing high levels of FRs and compared with human bronchial epithelial cells (16HBE) and human dermal fibroblasts (HDFa). The property of the nanosystems of efficiently controlling drug release upon NIR laser irradiation and of acting as an excellent hyperthermia agent as well as Two Photon Luminescence imaging contrast agents was demonstrated. The proposed folate-targeted GNRs have also been tested in terms of chemoterapeutic and thermoablation efficacy on tridimensional (3-D) osteosarcoma models.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Biocompatible Polymers, Department of Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), University of Palermo, Via Archirafi, 32, 90123 Palermo, Italy

Department of Physics and Chemistry, University of Palermo, 90123 Palermo, Italy

Mediterranean Center for Human Health Advanced Biotechnologies (CHAB), Aten Center, University of Palermo, 90129 Palermo, Italy

Funding

Ministero dell?Istruzione, dell?Universit? e della Ricerca · Universit? degli Studi di Palermo

References (45)

Show source-provided references
1. 10.1186/1749-799X-5-7810.1186/1749-799X-5-78 ↗
2. 10.1016/j.ctrv.2013.11.00610.1016/j.ctrv.2013.11.006 ↗
3. 10.1002/pbc.2468610.1002/pbc.24686 ↗
4. 10.1517/1742524090328042210.1517/17425240903280422 ↗
5. 10.1002/anie.20080258510.1002/anie.200802585 ↗
6. 10.1117/1.JBO.19.10.10150710.1117/1.JBO.19.10.101507 ↗
7. 10.1016/j.nano.2011.07.01110.1016/j.nano.2011.07.011 ↗
8. 10.1038/srep1738710.1038/srep17387 ↗
9. 10.1117/1.354450210.1117/1.3544502 ↗
10. 10.1002/smll.20040009310.1002/smll.200400093 ↗
11. 10.1016/j.colsurfb.2013.12.00810.1016/j.colsurfb.2013.12.008 ↗
12. 10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
13. 10.3109/02656736.2011.58736310.3109/02656736.2011.587363 ↗
14. 10.1016/j.canlet.2004.02.00410.1016/j.canlet.2004.02.004 ↗
15. 10.1002/adom.20150005310.1002/adom.201500053 ↗
16. 10.1016/j.jconrel.2016.04.00110.1016/j.jconrel.2016.04.001 ↗
17. 10.1016/j.jconrel.2014.09.02610.1016/j.jconrel.2014.09.026 ↗
18. 10.1080/1071754050039472910.1080/10717540500394729 ↗
19. 10.1021/jz400582h10.1021/jz400582h ↗
20. 10.1111/j.1751-1097.2008.00507.x10.1111/j.1751-1097.2008.00507.x ↗
21. 10.1021/acs.biomac.5b0070510.1021/acs.biomac.5b00705 ↗
22. 10.1155/2016/207831510.1155/2016/2078315 ↗
23. 10.1016/j.addr.2004.01.00810.1016/j.addr.2004.01.008 ↗
24. 10.1016/j.ejpb.2012.06.00110.1016/j.ejpb.2012.06.001 ↗
25. 10.1002/mabi.20080000910.1002/mabi.200800009 ↗
26. 10.1016/j.ijpharm.2005.10.01510.1016/j.ijpharm.2005.10.015 ↗
27. 10.1016/j.jconrel.2004.02.00310.1016/j.jconrel.2004.02.003 ↗
28. 10.1016/j.ijpharm.2007.07.04010.1016/j.ijpharm.2007.07.040 ↗
29. 10.1166/jbn.2013.160610.1166/jbn.2013.1606 ↗
30. 10.1158/1078-0432.CCR-06-134310.1158/1078-0432.CCR-06-1343 ↗
31. 10.1016/j.biomaterials.2011.08.08610.1016/j.biomaterials.2011.08.086 ↗
32. 10.1002/adma.20070197410.1002/adma.200701974 ↗
33. 10.1093/abbs/gms05310.1093/abbs/gms053 ↗
34. 10.1039/C4TB00955J10.1039/C4TB00955J ↗
35. 10.1016/j.biomaterials.2005.09.02710.1016/j.biomaterials.2005.09.027 ↗
36. 10.1039/c4tb00235k10.1039/c4tb00235k ↗
37. 10.1021/cm402177b10.1021/cm402177b ↗
38. 10.1021/acs.jpclett.5b0212310.1021/acs.jpclett.5b02123 ↗
39. 10.1007/s11095-007-9284-610.1007/s11095-007-9284-6 ↗
40. 10.1038/ncb331210.1038/ncb3312 ↗
41. 10.1016/j.gde.2013.11.01210.1016/j.gde.2013.11.012 ↗
42. 10.1039/C5TB01810B10.1039/C5TB01810B ↗
43. 10.1021/la034209c10.1021/la034209c ↗
44. 10.1016/j.addr.2011.03.00510.1016/j.addr.2011.03.005 ↗
45. Wei A. · National Inst. Heal. Public Access · 2008 · 2 · 125